BG Medicine, Inc. (BGMD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 17, 2026, 9:30 AM EST
BG Medicine Company Description
BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally.
It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke.
The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004.
BG Medicine, Inc. was incorporated in 2000 and is headquartered in Waltham, Massachusetts.
BG Medicine, Inc.
| Country | United States |
| Founded | 2000 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Paul Sohmer |
Contact Details
Address: 303 Wyman Street Waltham, Massachusetts 02451 United States | |
| Phone | 781 890 1199 |
| Website | bg-medicine.com |
Stock Details
| Ticker Symbol | BGMD |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US08861T2069 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Stephen P. Hall | Chief Financial Officer, Executive Vice President and Treasurer |